The most durable advantages in agentic AI aren’t being built in a model lab. They’re accumulating inside company workflows, and the window for investors to buy at a good price is closing.

The conventional approach of backing the best model to win the market misses the reality of what's happening on the ground. Today’s best models will become commodities within six to 12 months. What doesn't commoditize is how deeply a system is embedded in how companies operate.

 

Governance and trust are the first barriers. Enterprises don't adopt agentic AI the way they adopt software; they extend trust like they would to a new colleague. An agent that operates inside financial workflows, security operations, or customer-facing processes must earn the right to act autonomously.

This means that from Day 1, these systems must be built with explainability, audit trails, and confidence thresholds in mind. In workflows where certifications take 12 to 18 months to earn, early movers have an edge.

Organizational context is the second. Every deployment makes the system smarter about how that specific enterprise operates—its people, its norms, its workflows. That intelligence isn't easily transferable to a new vendor. A competitor with a better model still starts from zero on the context that makes the model useful.

Workflow integration is the third, and the most structural. When an agentic system is built into how a team works, replacing it means rebuilding how the team works. The switching costs are less about dollars and more about process changes, retraining, and the performance hit during transition.

Platform-scale companies with deep workflow ownership are on a different trajectory than point solutions, which face increasing acquisition pressure as their features get absorbed into broader stacks.

Enterprise agentic AI investment reached $24.2 billion last year. The selection event is already in progress, and entering late means paying a premium for switching costs that accrued to earlier investors.

Go deeper on the investment landscape in Agentic AI: The Evolution to Autonomous Systems: Part I. Hear how founders and executives describe where agentic AI is being deployed in Part II.

Agtech's postboom (2023-present) narrative has been dominated by capital destruction, and not without reason.

Our dataset confirms $8.2 billion in known VC-backed losses, with 2025 posting the highest annual confirmed failure count on record.

But that headline obscures a more useful story. The comprehensive outcome data in our latest analyst note reveals a surprisingly specific and repeatable profile of what actually works in agtech investing, and it looks nothing like how most capital was deployed during the 2020-2022 boom.

Of 1,197 VC-backed agtech companies with known outcomes through year-end 2025, only 142 (just 11.9%) exited with a disclosed valuation. The rest either failed outright or exited without a disclosed value, which almost always means small or distressed. That 11.9% is the denominator every return expectation in this sector should be measured against, and most are not.

The companies that do exit well cluster in three segments: crop inputs & enhancements, precision ag and animal ag. The acquirer base in biochem & inputs (Bayer, BASF, Syngenta, Novozymes, and Corteva) is not just active but strategically motivated, executing a documented shift toward biological alternatives driven by regulatory pressure on synthetic pesticides. That makes it the one agtech segment where the exit market is structurally growing, not cyclical.

 

The investor-level data is equally pointed. Domain specialists (corporate VCs and agtech-focused funds) post an 80% median exit rate versus 67% for generalists. Novo Holdings, Khosla Ventures, and Fall Line Capital all produced top-tier outcomes through the same discipline: biochem or precision ag focus, early-stage entry, and pre-established relationships with the serial acquirers who drive large exits.

Portfolio size mattered less than we expected. What mattered was whether the investor brought genuine domain conviction to every position.

The profile that works is narrow: seed or Series A entry below $20 million pre-money, technology suppliers rather than operators, total capital raised under $30 million, and the patience to hold for six to eight years. PE buyouts, up 5.2x from preboom (2014-2019) levels, are emerging as the most underweighted exit path, with the best capital efficiency of any realistic channel.

The question for the rest of 2026 is not whether agtech can produce returns. The data shows it can, and names the segments, the entry points, and the investors who have done it. The question is whether LPs and GPs will underwrite the discipline the data demands, or keep allocating to the profile that the boom already proved does not work.

Read more in our analyst note: What Does a "Good" Investment Look Like in Agtech?